Correlation Between Hookipa Pharma and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Vaccinex, you can compare the effects of market volatilities on Hookipa Pharma and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Vaccinex.

Diversification Opportunities for Hookipa Pharma and Vaccinex

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Hookipa and Vaccinex is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Vaccinex go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Vaccinex

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Vaccinex. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 3.11 times less risky than Vaccinex. The stock trades about -0.31 of its potential returns per unit of risk. The Vaccinex is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  340.00  in Vaccinex on September 28, 2024 and sell it today you would lose (228.00) from holding Vaccinex or give up 67.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Hookipa Pharma  vs.  Vaccinex

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Hookipa Pharma and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and Vaccinex

The main advantage of trading using opposite Hookipa Pharma and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Hookipa Pharma and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world